PL4034122T3 - Sposoby leczenia hiperfenyloalaninemii - Google Patents

Sposoby leczenia hiperfenyloalaninemii

Info

Publication number
PL4034122T3
PL4034122T3 PL20789788.5T PL20789788T PL4034122T3 PL 4034122 T3 PL4034122 T3 PL 4034122T3 PL 20789788 T PL20789788 T PL 20789788T PL 4034122 T3 PL4034122 T3 PL 4034122T3
Authority
PL
Poland
Prior art keywords
methods
hyperphenylalaninemia
treating
treating hyperphenylalaninemia
Prior art date
Application number
PL20789788.5T
Other languages
English (en)
Inventor
Niel SMITH
Original Assignee
Ptc Therapeutics Mp, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ptc Therapeutics Mp, Inc. filed Critical Ptc Therapeutics Mp, Inc.
Publication of PL4034122T3 publication Critical patent/PL4034122T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL20789788.5T 2019-09-25 2020-09-25 Sposoby leczenia hiperfenyloalaninemii PL4034122T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962905720P 2019-09-25 2019-09-25
PCT/US2020/052871 WO2021062264A1 (en) 2019-09-25 2020-09-25 Methods for treating hyperphenylalaninemia

Publications (1)

Publication Number Publication Date
PL4034122T3 true PL4034122T3 (pl) 2026-01-26

Family

ID=72827023

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20789788.5T PL4034122T3 (pl) 2019-09-25 2020-09-25 Sposoby leczenia hiperfenyloalaninemii

Country Status (23)

Country Link
US (1) US20220362249A1 (pl)
EP (1) EP4034122B1 (pl)
JP (2) JP7661315B2 (pl)
KR (1) KR20220070477A (pl)
CN (1) CN114650825A (pl)
AU (1) AU2020353676A1 (pl)
BR (1) BR112022003719A2 (pl)
CA (1) CA3150003A1 (pl)
DK (1) DK4034122T3 (pl)
ES (1) ES3041002T3 (pl)
FI (1) FI4034122T3 (pl)
HR (1) HRP20251268T1 (pl)
HU (1) HUE073483T2 (pl)
IL (1) IL291565A (pl)
JO (1) JOP20220042A1 (pl)
LT (1) LT4034122T (pl)
MX (1) MX2022003585A (pl)
PL (1) PL4034122T3 (pl)
PT (1) PT4034122T (pl)
RS (1) RS67295B1 (pl)
SI (1) SI4034122T1 (pl)
SM (1) SMT202500493T1 (pl)
WO (1) WO2021062264A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017366879C1 (en) 2016-11-29 2022-08-11 Ptc Therapeutics Mp, Inc. Polymorphs of sepiapterin and salts thereof
MX391156B (es) 2016-11-29 2025-03-21 Ptc Therapeutics Mp Inc Forma polimorfica de sepiapterina.
JP7811085B2 (ja) 2017-09-01 2026-02-04 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリンを含む医薬組成物及びその使用
US12257252B2 (en) * 2018-05-30 2025-03-25 Ptc Therapeutics Mp, Inc. Compositions and methods for increasing tetrahydrobiopterin plasma exposure
WO2019232130A1 (en) 2018-05-30 2019-12-05 Censa Pharmaceuticals Inc. Methods for increasing sepiapterin plasma exposure

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910304A (en) 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
CA1320905C (en) 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
US6036949A (en) 1998-03-05 2000-03-14 Amarillo Biosciences, Inc. Treatment of fibromyalgia with low doses of interferon
ES2586945T3 (es) * 2014-03-31 2016-10-19 Vasopharm Gmbh Composiciones farmacéuticas sólidas que comprenden derivados de biopterina y usos de dichas composiciones
AU2017366879C1 (en) * 2016-11-29 2022-08-11 Ptc Therapeutics Mp, Inc. Polymorphs of sepiapterin and salts thereof
MX391156B (es) 2016-11-29 2025-03-21 Ptc Therapeutics Mp Inc Forma polimorfica de sepiapterina.
JP7811085B2 (ja) * 2017-09-01 2026-02-04 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリンを含む医薬組成物及びその使用
CN112543758A (zh) 2018-05-30 2021-03-23 Ptc医疗Mp公司 墨蝶呤的药学上可接受的盐

Also Published As

Publication number Publication date
FI4034122T3 (fi) 2025-10-08
JOP20220042A1 (ar) 2023-01-30
EP4034122B1 (en) 2025-08-13
HRP20251268T1 (hr) 2025-12-05
JP2025111476A (ja) 2025-07-30
US20220362249A1 (en) 2022-11-17
ES3041002T3 (en) 2025-11-06
PT4034122T (pt) 2025-09-18
WO2021062264A1 (en) 2021-04-01
SMT202500493T1 (it) 2026-01-12
AU2020353676A1 (en) 2022-04-14
MX2022003585A (es) 2022-04-19
RS67295B1 (sr) 2025-11-28
CN114650825A (zh) 2022-06-21
HUE073483T2 (hu) 2026-01-28
IL291565A (en) 2022-05-01
KR20220070477A (ko) 2022-05-31
EP4034122A1 (en) 2022-08-03
DK4034122T3 (da) 2025-09-15
BR112022003719A2 (pt) 2022-05-31
JP7661315B2 (ja) 2025-04-14
LT4034122T (lt) 2025-11-10
JP2022549834A (ja) 2022-11-29
CA3150003A1 (en) 2021-04-01
SI4034122T1 (sl) 2025-12-31

Similar Documents

Publication Publication Date Title
IL287907A (en) Cancer treatment methods
GB201903079D0 (en) Process
GB201903080D0 (en) Process
SG10201913409VA (en) Methods for solid tumor treatment
IL291565A (en) A method for treating phenylalanine irregularity
GB201901061D0 (en) Process
SG11202109760YA (en) Electropolishing method
GB201907659D0 (en) Process
PL3638630T3 (pl) Sposób obróbki szlamu
SG11202010528XA (en) Combinations for treating cancer
PL4048284T4 (pl) Metoda leczenia nowotworów
SG11202102878TA (en) Treatment methods
SG11202102827YA (en) Treatment methods
SG11202102416SA (en) Methods for treating pancreatitis
GB201905107D0 (en) Process
GB201902646D0 (en) Process
IL284668A (en) Methods of treating schizophrenia
HUE049463T2 (hu) Eljárás kavicsok kezelésére
ZA202001536B (en) Method for the treatment of wastewaters
GB201914296D0 (en) Treatment
GB201912365D0 (en) Treatment
GB201901069D0 (en) Process
IL287840A (en) treatment system
GB201912453D0 (en) Treatment process
GB201910244D0 (en) Method for treating cancer